The data have been submitted to the pre-print server medRxiv by the studies’ authors, with anticipation of publication in peer-reviewed journals.Data from the Sisonke 2 trial, which included 227,310 healthcare workers in South Africa who received the single-shot Johnson & Johnson Covid-19 vaccine as a primary dose, show that the Johnson & Johnson Covid-19 booster increased vaccine effectiveness (VE) against hospitalization to 85 per cent.When a booster shot was administered six to nine months after a primary single dose, VE increased over time from 63 per cent at 0-13 days, to 84 per cent at 14-27 days and 85 per cent at 1-2 months post-boost.Sisonke 2 was conducted in approximately 350 vaccination centres across all nine provinces of South Africa.Utilising data from a South African managed care organisation, trial investigators determined VE of the Johnson & Johnson Covid-19 booster shot (ni,092) as compared to other individuals enrolled in the same managed care organisation, during the period from November 15, 2021, through December 20, 2021.
Source link
बदरीनाथ धाम ने सर्दियों के लिए बंद कर दिया है, जिसमें रिकॉर्ड तीर्थयात्रियों की भीड़ थी।
देहरादून: बद्रीनाथ धाम, जो पवित्र चार धाम यात्रा का आधार है, के पवित्र द्वारों को मंगलवार को दोपहर…
